Vir Biotechnology (VIR) Invested Capital (2019 - 2025)

Vir Biotechnology has reported Invested Capital for 5 years, with the latest figure at $17.5 million in Q1 2025.

• Quarterly Invested Capital changed N/A year-over-year to $17.5 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $17.5 million (up 8.97% YoY) and the FY2024 annual result came in at $16.1 million, changed N/A from the prior year.
• Invested Capital improved to $17.5 million in Q1 2025 per VIR's latest filing, from $16.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $68.5 million in Q3 2021 and troughed at $16.1 million in Q4 2024.
• A 3-year average of $30.5 million and a median of $24.4 million in 2021 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 457.45% in 2021, down 128.04% in 2021.
• Over 3 years, Invested Capital stood at $68.5 million in 2021, then slumped by 76.55% to $16.1 million in 2024, then rose by 8.97% to $17.5 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $17.5 million, $16.1 million, and $68.5 million for Q1 2025, Q4 2024, and Q3 2021 respectively.